- Home
- HSHP vs RGNX Comparison
HSHP vs RGNX Comparison
Compare HSHP & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSHP
- RGNX
- Stock Information
- Founded
- HSHP 2021
- RGNX 2008
- Country
- HSHP Bermuda
- RGNX United States
- Employees
- HSHP N/A
- RGNX N/A
- Industry
- HSHP
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HSHP
- RGNX Health Care
- Exchange
- HSHP Nasdaq
- RGNX Nasdaq
- Market Cap
- HSHP 314.8M
- RGNX 372.1M
- IPO Year
- HSHP 2023
- RGNX 2015
- Fundamental
- Price
- HSHP $4.91
- RGNX $7.57
- Analyst Decision
- HSHP
- RGNX Strong Buy
- Analyst Count
- HSHP 0
- RGNX 12
- Target Price
- HSHP N/A
- RGNX $35.55
- AVG Volume (30 Days)
- HSHP 131.0K
- RGNX 1.8M
- Earning Date
- HSHP 01-01-0001
- RGNX 02-25-2025
- Dividend Yield
- HSHP 9.51%
- RGNX N/A
- EPS Growth
- HSHP N/A
- RGNX N/A
- EPS
- HSHP 0.57
- RGNX N/A
- Revenue
- HSHP $112,303,000.00
- RGNX $84,327,000.00
- Revenue This Year
- HSHP $260.76
- RGNX $2.92
- Revenue Next Year
- HSHP $18.68
- RGNX $256.82
- P/E Ratio
- HSHP $8.69
- RGNX N/A
- Revenue Growth
- HSHP 509.85
- RGNX N/A
- 52 Week Low
- HSHP $4.54
- RGNX $6.56
- 52 Week High
- HSHP $9.76
- RGNX $28.80
- Technical
- Relative Strength Index (RSI)
- HSHP 40.74
- RGNX 45.51
- Support Level
- HSHP $4.92
- RGNX $6.98
- Resistance Level
- HSHP $5.24
- RGNX $7.70
- Average True Range (ATR)
- HSHP 0.15
- RGNX 0.54
- MACD
- HSHP 0.07
- RGNX 0.04
- Stochastic Oscillator
- HSHP 31.35
- RGNX 44.30
About HSHP Himalaya Shipping Ltd.
Himalaya Shipping Ltd is an independent dry bulk company that focuses on owning and operating its Newcastlemax dry bulk carriers.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.